Immediate Impact

60 standout
Sub-graph 1 of 22

Citing Papers

A covalent peptide-based lysosome-targeting protein degradation platform for cancer immunotherapy
2025 Standout
Spatial determinants of antibody-drug conjugate SHR-A1811 efficacy in neoadjuvant treatment for HER2-positive breast cancer
2025 Standout
4 intermediate papers

Works of Fernando Ortiz-Martínez being referenced

Src, a potential target for overcoming trastuzumab resistance in HER2-positive breast carcinoma
2014
Increased signalling of EGFR and IGF1R, and deregulation of PTEN/PI3K/Akt pathway are related with trastuzumab resistance in HER2 breast carcinomas
2012

Author Peers

Author Last Decade Papers Cites
Fernando Ortiz-Martínez 220 219 25 120 12 417
Tim Nichols 262 155 11 74 12 409
Caterina Viscomi 196 256 17 55 11 419
Brett H. Simmons 257 199 35 124 9 481
Gillian Bethune 185 214 19 112 18 466
C Mazeau 228 168 10 93 16 394
Cathy C. Zhang 284 192 10 89 13 456
Wende Kozlow 190 321 32 63 8 482
Jelena Urosevic 216 220 13 109 10 447
Guadalupe Lorenzatti Hiles 219 169 17 87 16 381
Ted Shih 198 217 6 91 9 509

All Works

Loading papers...

Rankless by CCL
2026